[Rheohepatographic changes under the effect of clinical trials of drugs in chronic nonspecific lung diseases].
D000628:Aminophylline / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004809:Ephedrine / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008102:Liver Circulation / Q000187:drug effects*; D010208:Papaverine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010992:Plethysmography, Impedance; D011014:Pneumonia / Q000188:drug therapy*; D013328:Strophanthins / Q000627:therapeutic use
D001993:Bronchodilator Agents; D013328:Strophanthins; D000628:Aminophylline; C005317:drotaverin; D010208:Papaverine; D004809:Ephedrine; D007545:Isoproterenol
Izmeneniia reogepatogrammy pod vliianiem farmakologicheskikh prob pri khronicheskikh nespetsificheskikh zabolevaniiakh legkikh.